News

Investigators find that mutations could lead to early treatment intervention.

Organizations are urging consumers to be aware of insurance policies that can limit their access to sight-saving procedures and treatments.

Staying current on phaco technology can help surgeons provide better outcomes.

Aldeyra Therapeutics announced today that it has achieved the primary endpoint of ocular redness in its randomly assigned, double-masked, vehicle-controlled Phase 2 clinical trial in dry eye disease.

The FDA has given its approval to Byooviz (ranibizumab-nuna, SB11, Samsung Bioepis Co Inc and Biogen Inc), a biosimilar referencing Lucentis (ranibizumab, Genentech).

Allergan developed VUITY, which it noted is the first and only FDA-approved eye drop to treat presbyopia.

Investigators in Australia are developing a new rapid screening test for glaucoma that could help advance early detection of the disease.

The Cleveland Clinic named Rishi Singh, MD, president of the Cleveland Clinic Martin North and South hospitals in Martin County, Florida.

According to investigators, the SARS-CoV-2 spike protein physically interacts with GRP78 on the cell surface in patients with diabetes and promotes the binding to and accumulation in angiotensin-converting enzyme 2 (ACE2)-expressing cells.

Ongoing nationwide study looks at in vitro antibiotic resistance among isolates.

Sustained-release option is deposited directly into the lenticular capsule.

A team of investigators from the University of Michigan may have unlocked a potential new recipe for counteracting the impact that COVID-19 has on patients with underlying disease processes such as type 2 diabetes.

Patients can get real-time disease monitoring with self-operated device.

The study investigated rates of cognitive impairment among survivors of COVID-19 who had been treated in outpatient, emergency department, or inpatient hospital settings.

The Academy's annual meeting set for November 12 to 15 in New Orleans.

According to investigators, the risk of death from strokes, heart attacks and other vascular causes is increased by more than a third.

Improvements are seen after gene therapy for Leber congenital amaurosis.

According to a team of French investigators, every patient hospitalized with severe COVID-19 cases in their study had retinal and choroidal anomalies on indocyanine green angiography and optical coherence tomography images that were possibly related to the virus.

Bausch + Lomb and Clearside Biomedical announced Monday that the U.S. Food and Drug Administration has approved XIPERE (triamcinolone acetonide injectable suspension) for suprachoroidal use for the treatment of macular edema associated with uveitis.

Investigators have found that the early and late stages of uveal melanoma differ markedly.

All of the newborns in a recent study had ocular manifestations, the most common being periorbital edema and hemorrhagic conjunctivitis,

See the latest cartoon!

The development of involutional ptosis may be a multifactorial process, researchers have found.

According to the company, Susvimo is a first-of-its-kind therapeutic approach for wet AMD and may help people with the disease maintain their vision with as few as two treatments per year.

Three cases demonstrate value of new tools, technology for surgeons.

A coalition of vision groups held a briefing on Capitol Hill this week to educate legislators on increasing incidence of myopia and the associated cost burden.

Fellowship recipient Christopher J. Kaler will explore functional links between BAP1 loss and aberrant activity of the nucleosome remodeling and deacetylase complex, which normally mediates embryonic lineage commitment and cellular differentiation.

According to investigators, aqueous humor analysis differentiated the tumors in patients.